These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26756979)

  • 1. Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.
    Cantarini L; Pucino V; Vitale A; Talarico R; Lucherini OM; Magnotti F; De Rosa V; Galgani M; Alviggi C; Marone G; Galeazzi M; Matarese G
    Clin Exp Immunol; 2016 May; 184(2):197-207. PubMed ID: 26756979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.
    Lopalco G; Lucherini OM; Vitale A; Talarico R; Lopalco A; Galeazzi M; Lapadula G; Cantarini L; Iannone F
    Medicine (Baltimore); 2015 Oct; 94(42):e1858. PubMed ID: 26496336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.
    Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
    Uchio E; Matsumoto T; Tanaka SI; Ohno S
    Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease.
    Lopalco G; Lucherini OM; Lopalco A; Venerito V; Fabiani C; Frediani B; Galeazzi M; Lapadula G; Cantarini L; Iannone F
    Front Immunol; 2017; 8():200. PubMed ID: 28289419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
    Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
    Keskin D; Keskin G; Inal A; Ozışık L
    Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease.
    Lee HJ; Kim JH; Kim SW; Joo HA; Lee HW; Kim YS; Park SJ; Hong SP; Kim TI; Kim WH; Kim YH; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):1953-1962. PubMed ID: 28523576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble CD30 levels in Behçet's disease.
    Düzgün N; Ayaslioglu E; Tutkak H
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S17-20. PubMed ID: 15515777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.
    Sota J; Vitale A; Rigante D; Orlando I; Lucherini OM; Simpatico A; Lopalco G; Franceschini R; Galeazzi M; Frediani B; Fabiani C; Tosi GM; Cantarini L
    Isr Med Assoc J; 2018 Aug; 20(8):517-521. PubMed ID: 30084580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease.
    Perazzio SF; Soeiro-Pereira PV; Dos Santos VC; de Brito MV; Salu B; Oliva MLV; Stevens AM; de Souza AWS; Ochs HD; Torgerson TR; Condino-Neto A; Andrade LEC
    Arthritis Res Ther; 2017 Oct; 19(1):235. PubMed ID: 29052524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.
    Talaat RM; Sibaii H; Bassyouni IH; El-Wakkad A
    Eur Cytokine Netw; 2019 Mar; 30(1):15-22. PubMed ID: 31122907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.